Eric Huang, Ph.D., is the General Manager and Chief Scientific Officer of Moderna Genomics, an independent research and business unit for genomic medicines founded by Moderna. In this role, Dr. Huang is responsible for setting the portfolio strategy, creating a product pipeline and a robust discovery engine, and building a new high-performing team. He was formerly the CSO of Moderna’s New Venture Labs, an internal incubator where a select group of scientists explores novel clinical applications of Moderna’s mRNA technology. Moderna’s infectious diseases vaccine platform that led to the COVID-19 vaccine was conceptualized under Dr. Huang’s leadership. Prior to joining Moderna in 2012, Dr. Huang held several positions within business and corporate development at biotechnology companies including Seaside Therapeutics, Stromedix, and Domantis.
Dr. Huang obtained his Ph.D. degree in Molecular and Medical Parasitology from New York School of Medicine and MBA degree from Boston University. He received his B.S. degree from Emory University.